CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
+13.85%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$1.72B
AUM Growth
+$1.72B
(-6.8%)
Cap. Flow
-$378M
Cap. Flow
% of AUM
-21.9%
Top 10 Holdings %
Top 10 Hldgs %
60.63%
Holding
38
New
4
Increased
8
Reduced
6
Closed
9
Top Buys
| 1 |
DaVita
DVA
|
$72.3M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$54.9M |
| 3 |
Bristol-Myers Squibb
BMY
|
$52.5M |
| 4 |
Ascendis Pharma
ASND
|
$50.6M |
| 5 |
AGN
Allergan plc
AGN
|
$43.9M |
Top Sells
| 1 |
TSRO
TESARO, Inc.
TSRO
|
$208M |
| 2 |
McKesson
MCK
|
$96.7M |
| 3 |
CELG
Celgene Corp
CELG
|
$96.1M |
| 4 |
GSK
GSK
|
$76.4M |
| 5 |
ELGX
Endologix Inc
ELGX
|
$55.3M |
Sector Composition
| 1 | Healthcare | 93.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ELGX
26
DELISTED
Endologix Inc
ELGX
| $6.15M | 0.31% | 930,001 -8,369,999 | -90% | -$55.3M |
|
27
Surgery Partners
SGRY
$2.91B
| $1.81M | 0.09% | 160,084 | – | – |
|
28
Alnylam Pharmaceuticals
ALNY
$58.5B
| – | – | -600,000 | Closed | -$43.7M |
|
29
Bausch Health
BHC
$2.74B
| – | – | -1,000,000 | Closed | -$18.5M |
|
30
Cardinal Health
CAH
$35.5B
| – | – | 0 | – | – |
|
|
31
GSK
GSK
$79.9B
| – | – | -2,000,000 | Closed | -$76.4M |
|
32
HCA Healthcare
HCA
$94.5B
| – | – | -250,000 | Closed | -$31.1M |
|
|
33
McKesson
MCK
$85.4B
| – | – | -875,000 | Closed | -$96.7M |
|
34
Puma Biotechnology
PBYI
$254M
| – | – | -1,300,000 | Closed | -$26.5M |
|
35
SPDR S&P 500 ETF Trust
SPY
$658B
| – | – | 0 | – | – |
|
|
ARNA
36
DELISTED
Arena Pharmaceuticals Inc
ARNA
| – | – | -500,000 | Closed | -$19.5M |
|
|
TSRO
37
DELISTED
TESARO, Inc.
TSRO
| – | – | -2,800,000 | Closed | -$208M |
|
|
CELG
38
DELISTED
Celgene Corp
CELG
| – | – | -1,500,000 | Closed | -$96.1M |
|